Skip to main content
PYPD
NASDAQ Life Sciences

PolyPid Posts $7.8M Q2 Loss, $6.6M Cash; $5.8M Raised in July Extends Runway to Q2 2027

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4.46
Mkt Cap
$90.264M
52W Low
$3.06
52W High
$5.73
52W Position info
46% above low
Off High info
22% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

PYPD sits 46% above its 52-week low of $3.06 on light trading volume (0.4× avg).

Summary

PolyPid reported a Q2 net loss of $7.8M with only $6.6M in cash at quarter-end, but raised $5.8M in July through warrant exercises and ATM sales, extending its cash runway into Q2 2027. This follows the transformative Azurity licensing deal and FDA Priority Review acceptance for D-PLEX100, which brought in $30M in upfront and near-term milestones. The financial update is critical given the company's pre-revenue stage and the need to fund operations through the November 28 PDUFA date and potential early 2027 launch. The conference call at 8:30 AM ET may provide additional color on spending and milestone timing.

At the time of this announcement, PYPD was trading at $4.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $90.3M. The 52-week trading range was $3.06 to $5.73. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PYPD - Latest Insights

PYPD
Nov 12, 2026, 8:39 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $6.97
Real-time Price: $6.16 info
Change: -$0.815 (-12%) info
Market Cap: $130.768M info
PYPD
Nov 11, 2026, 9:31 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $6.22
Real-time Price: $6.16 info
Change: -$0.0641 (-1%) info
Market Cap: $130.768M info
PYPD
Oct 28, 2026, 8:03 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.75
Real-time Price: $6.16 info
Change: +$0.405 (+7%) info
Market Cap: $130.768M info
PYPD
Oct 01, 2026, 9:20 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $6.16 info
Change: +$0.855 (+16%) info
Market Cap: $130.768M info
PYPD
Oct 01, 2026, 8:56 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.27
Real-time Price: $6.16 info
Change: +$0.885 (+17%) info
Market Cap: $130.768M info